Vikram Karnani's most recent trade in Collegium Pharmaceutical Inc was a trade of 130,344 Stock Option (Right to Purchase) done . Disclosure was reported to the exchange on Nov. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc | Vikram Karnani | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 130,344 | 130,344 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Vikram Karnani | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 105,972 | 105,972 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Sale of securities on an exchange or to another person at price $ 87.08 per share. | 22 Feb 2021 | 7,713 | 104,810 (0%) | 0% | 87.1 | 671,671 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Sale of securities on an exchange or to another person at price $ 88.45 per share. | 22 Feb 2021 | 645 | 104,165 (0%) | 0% | 88.4 | 57,050 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 14,512 | 14,512 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,931 | 3,931 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,965 | 113,394 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.17 per share. | 17 Feb 2021 | 871 | 112,523 (0%) | 0% | 87.2 | 75,925 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 4,904 | 116,333 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 4,904 | 4,905 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Sale of securities on an exchange or to another person at price $ 76.81 per share. | 21 Jan 2021 | 2,731 | 111,429 (0%) | 0% | 76.8 | 209,768 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.43 per share. | 21 Jan 2021 | 2,173 | 114,160 (0%) | 0% | 77.4 | 168,255 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 06 Jan 2021 | 30,031 | 111,429 (0%) | 0% | 75 | 2,252,325 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 65,088 | 191,366 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.28 per share. | 04 Jan 2021 | 49,906 | 141,460 (0%) | 0% | 73.3 | 3,657,112 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 47,337 | 126,278 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 20,957 | 20,957 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,983 | 17,983 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,260 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 12,094 | 24,190 | - | - | Restricted Stock Units (RSU) |